Abstract
To evaluate the effect of doxorubicin and its pegylated liposomal formulation (Doxil, Caelyx) on invitro susceptibility of promastigote and amastigote stages of Leishmania major. Throughout invitro assays the IC50 was calculated in the promastigotes and amastigotes forms in J774 macrophage cell line. Also as cytotoxicity in J774cell line macrophages. Doxorubicin and Doxil showed the same activity against promastigote form with IC50 values of 10.49μg/mL and 9.63μg/mL, respectively. Similarly, the amastigote stage was susceptible at concentration of at least 1μg/mL when compared to positive control (P<0.0001). Also, cytotoxicity assay against macrophage revealed no toxicity on the host cells at IC50 concentrations. Our findings demonstrated the efficacy of both doxorubicin and its pegylated liposomal formulation on L. major at low concentrations. Further researches are needed for evaluating the safety of drugs in animal model particularly as topical formulation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
